BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20467172)

  • 1. The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
    Okamoto K; Ishida C; Ikebuchi Y; Mandai M; Mimura K; Murawaki Y; Yuasa I
    Intern Med; 2010; 49(10):887-95. PubMed ID: 20467172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
    Okamoto K; Mandai M; Mimura K; Murawaki Y; Yuasa I
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():77-89. PubMed ID: 18426080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene polymorphisms of Interleukin 1? and Metalloproteinase 3 in Hepatitis C Infected Patients and Hepatocellular Carcinoma Patients.
    ElSheshtawy NM; Nour MS; Hefny Z; Samir A
    Egypt J Immunol; 2017 Jan; 24(1):1-8. PubMed ID: 29120572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
    Okamoto K; Mimura K; Murawaki Y; Yuasa I
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
    Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
    Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
    Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
    Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Badawy AA; Othman G; Elabbasy LM; Abd Elsalam M; Shrief R; Fahmy EM; Kamel NM; Osman A; Zaki ME
    Br J Biomed Sci; 2019 Oct; 76(4):201-204. PubMed ID: 31314698
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.
    Ghilardi G; Biondi ML; DeMonti M; Turri O; Guagnellini E; Scorza R
    Stroke; 2002 Oct; 33(10):2408-12. PubMed ID: 12364729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection.
    Hirankarn N; Kimkong I; Kummee P; Tangkijvanich P; Poovorawan Y
    World J Gastroenterol; 2006 Feb; 12(5):776-9. PubMed ID: 16521194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
    Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
    J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
    Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis C.
    Miyoshi K; Ikebuchi Y; Ishida C; Okamoto K; Murawaki Y
    Intern Med; 2014; 53(14):1461-8. PubMed ID: 25030555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
    Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan.
    Tanaka Y; Furuta T; Suzuki S; Orito E; Yeo AE; Hirashima N; Sugauchi F; Ueda R; Mizokami M
    J Infect Dis; 2003 Jun; 187(11):1822-5. PubMed ID: 12751042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions.
    Collazos J; Asensi V; Martin G; Montes AH; Suárez-Zarracina T; Valle-Garay E
    Clin Exp Immunol; 2015 Nov; 182(2):213-9. PubMed ID: 26206176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
    Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India.
    Saxena R; Chawla YK; Verma I; Kaur J
    J Interferon Cytokine Res; 2013 Feb; 33(2):80-9. PubMed ID: 23210983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
    El Samanoudy A; Monir R; Badawy A; Ibrahim L; Farag K; El Baz S; Alenizi D; Alenezy A
    Genet Mol Res; 2014 Sep; 13(3):8025-34. PubMed ID: 25299117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.